Dr. Eric A. Rose, M.D. has a substantial background in medicine, holding an M.D. from a recognized medical school. He became the CEO of SIGA Technologies, Inc. on March 1, 2007, where he worked until December 31, 2010. During his...
Dr. Eric A. Rose, M.D. has a substantial background in medicine, holding an M.D. from a recognized medical school. He became the CEO of SIGA Technologies, Inc. on March 1, 2007, where he worked until December 31, 2010. During his tenure, Dr. Rose was paid a steady salary of $400,000 with no bonuses awarded, reflecting a conservative approach to executive compensation. His employment agreement included provisions that ensured he would receive his salary for a year if terminated without cause. Most notably, he played a key role in guiding the company through significant changes and challenges in the pharmaceutical sector. After stepping down as CEO, he transitioned to the role of Executive Chairman, showing his lasting commitment to the company's vision. In terms of insider trading, Dr. Rose was active in managing his holdings, peaking in value at over $22 million in August 2022. This reflects both his confidence in SIGA and the trust investors place in his leadership.